Drug-induced bullous Sweet's syndrome by celecoxib

J Dermatol. 2016 Sep;43(9):1092-3. doi: 10.1111/1346-8138.13337. Epub 2016 Apr 6.

Authors

Eui Hyun Oh¹, Jae Min Shin¹, Jeong Ho Hong¹, Ji Sook Kim², Young Suck Ro¹, Joo Yeon Ko¹

Affiliations

¹ Department of Dermatology, College of Medicine, University of Hanyang, Seoul, Korea.
² Department of Pathology, College of Medicine, University of Hanyang, Seoul, Korea.

PMID: 27060586
DOI: 10.1111/1346-8138.13337

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Antirheumatic Agents / therapeutic use
Arthralgia / drug therapy*
Arthritis, Rheumatoid / complications
Arthritis, Rheumatoid / drug therapy
Biopsy
Blister / blood
Blister / chemically induced*
Blister / drug therapy
Blister / pathology
Blood Sedimentation
C-Reactive Protein / analysis
Celecoxib / adverse effects*
Celecoxib / therapeutic use
Cyclooxygenase 2 Inhibitors / adverse effects*
Cyclooxygenase 2 Inhibitors / therapeutic use
Female
Fluorescent Antibody Technique, Direct
Glucocorticoids / therapeutic use*
Humans
Leukocyte Count
Lower Extremity
Middle Aged
Prednisolone / therapeutic use*
Rheumatoid Factor / blood
Skin / pathology
Sweet Syndrome / blood
Sweet Syndrome / chemically induced*
Sweet Syndrome / drug therapy
Sweet Syndrome / pathology
Withholding Treatment

Substances

Antirheumatic Agents
Cyclooxygenase 2 Inhibitors
Glucocorticoids
C-Reactive Protein
Rheumatoid Factor
Prednisolone
Celecoxib